NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 6.44% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 4.24% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.78% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.54% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.54% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.54% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 3.41% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 3.33% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.32% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.07% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.67% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.55% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.54% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.49% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.44% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.38% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.33% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.28% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 2.25% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 2.18% |